Genotoxicity in rats treated with the antidiabetic agent, rosiglitazone (Q79320582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Genotoxicity in rats treated with the antidiabetic agent, rosiglitazone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

Abdulkerim Bedir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Yuksel Aliyazicioglu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hakki Kahraman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Zafer Yurdakul

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Mehmet Uysal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Duygu Erol Suvaci

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ali Okuyucu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Murat Hökelek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Muhlise Alvur

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

Environmental and Molecular Mutagenesis

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

718-724

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Oxidative DNA damage, antioxidants, and cancer

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

The comet assay for DNA damage and repair: principles, applications, and limitations

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Thiazolidinediones: a new class of antidiabetic drugs

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

The steroid and thyroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Hepatic failure in a patient taking rosiglitazone

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver.

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

https://api.crossref.org/works/10.1002%2FEM.20261

1 reference

7 January 2021

Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Comet assay to detect nitric oxide-dependent DNA damage in mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Mechanisms and clinical effects of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Unraveling the mechanism of action of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

A cross-platform public domain PC image-analysis program for the comet assay

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Use of the single cell gel electrophoresis/comet assay for detecting DNA damage in aquatic (marine and freshwater) animals

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

The alkaline comet assay: towards validation in biomonitoring of DNA damaging exposures

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Troglitazone: a review of its use in the management of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

A simple technique for quantitation of low levels of DNA damage in individual cells

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

https://api.crossref.org/works/10.1002%2FEM.20261

1 reference

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Hepatic dysfunction associated with troglitazone

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2FEM.20261

7 January 2021

Identifiers

DOI

10.1002/EM.20261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17078099%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference